Handala ransomware group lists Innovalve 3TB ( $300M ) on its leak site

• Ransomware group: Handala
• Country: Israel
• Sector: Healthcare
• Announcement date: August 8, 2024

Handala claims to have leaked data from Innovalve

The threat actor known as Handala has announced a significant data breach involving Innovalve, a medical technology organization. According to a post on a leak site, the group claims to have exfiltrated a massive amount of information, specifically alleging the theft of 3TB of data. This announcement, which was published on August 8, 2024, identifies the alleged incident date as July 26, 2024.

The group has indicated that this cyberattack was not a random occurrence but was instead a targeted action. Handala states that the theft was carried out in response to the recent acquisition of the startup by Edwards Lifesciences. This suggests a motive tied to the corporate restructuring and the shifting ownership of the medical technology firm.

Details regarding the claimed data

While the volume of the data has been specified by the threat actor, the specific nature of the files remains unclear. The group has described the information as being "sensitive," but they have not provided a detailed breakdown or a specific inventory of the files that were allegedly stolen. Consequently, the listing names no specific data types.

In many modern cyberattacks, particularly those involving ransomware, threat actors utilize a tactic known as double extortion. In these scenarios, attackers do not just encrypt an organization's systems to demand a ransom for decryption; they also steal sensitive data to threaten its public release. This creates a secondary layer of pressure, as the victim faces the risk of regulatory penalties and reputational damage if their proprietary or personal information is leaked on the dark web.

About Innovalve

Innovalve is an Israel-based medical device startup that specializes in the development of innovative transcatheter mitral valve replacement technologies. These technologies are designed for the treatment of heart valve diseases. The company has a significant institutional history, having been founded within the Sheba Medical Center. Following its period of development and growth, the company was acquired by Edwards Lifesciences in 2024.

Potential impacts and industry implications

The alleged leak poses several significant risks to the involved entities. For Innovalve and its parent company, Edwards Lifesciences, the exposure of sensitive information may result in the loss of critical intellectual property. Furthermore, because the breach involves a company operating within the healthcare sector, the exposure of medical-related information could lead to complex compliance issues under relevant industry regulations.

Beyond corporate interests, such a breach can create direct risks for employees and various stakeholders. The exposure of sensitive data can facilitate identity theft or provide attackers with the necessary information to launch highly targeted phishing campaigns against individuals within the organization or its partner networks.

The Handala group, which is assessed to have ties to Iran, may be conducting this action as a politically motivated attack. For organizations operating in high-stakes sectors like healthcare and medical technology, such incidents underscore the importance of robust defensive measures. Common defensive strategies typically include implementing strict access controls, maintaining comprehensive logging and monitoring to detect unauthorized exfiltration, and ensuring that all software and systems are regularly patched to close vulnerabilities that attackers might exploit.